Multisite, double-blind, placebo-controlled trial of porcine secretin in autism

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 40, Issue 11, 2001, Pages 1293-1299

  Owley, Thomas ^a   Mcmahon, William ^b   Cook, Edwin H ^a   Laulhere, Tracy ^c   South, Mikle ^b   Zellmer Mays, Lee ^c   Shernoff, Elisa S ^a   Lainhart, Janet ^b   Modahl, Charlotte B ^c   Corsello, Christina ^a   Ozonoff, Sally ^b   Risi, Susan ^a   Lord, Catherine ^a   Leventhal, Bennett L ^a   Filipek, Pauline A ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autistic disorder; Pervasive developmental disorder; Psychopharmacology; Secretin

Indexed keywords

SECRETIN;

ARTICLE; AUTISM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVELOPMENTAL DISORDER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL;

EID: 0034779144     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200111000-00009     Document Type: Article

References (28)

1. Naltrexone in infantile autism
2. Naltrexone in autistic children: Behavioral symptoms and attentional learning
3. Secretin and autism: A two-part clinical investigation
4. Pediatric psychopharmacology, II: Autistic disorder and other pervasive developmental disorders
5. Effect of secretin on children with autism: A randomized controlled trial
6. Preliminary observations on the effect of fenfluramine on blood serotonin and symptoms in three autistic boys
7. Improved social and language skills after secretin administration in patients with autistic spectrum disorders
8. Clonidine treatment of hyperactive and impulsive children with autistic disorder
9. A double-blind, placebo-controlled study of amantidine hydrochloride in the treatment of children with autistic disorder
10. Clinical usefulness of the secretin provocation test
11. Clinical and neurochemical effects of fenfluramine in children with autism
12. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism
13. Autism diagnostic observation schedule: A standardized observation of communicative and social behavior
14. Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders
15. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder
16. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders
17. Rating scales and assessment instruments for use in pediatric psychopharmacology research
18. Double-blind, placebo-controlled trial of secretin for the treatment of autistic disorder
19. Repeated doses of porcine secretin in the treatment of autism: A randomized, placebo-controlled trial
20. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder